Pfizer Chairman and CEO Albert Bourla did not mince his words at the ... is going to do in terms of vaccines. But Stéphane Bancel went on to add the following in more detail: The piece that ...

Stephane Bancel, CEO, Moderna speaks at the Fast Company Innovation Festival at Convene on September 21, 2023 in New York City. Pfizer CEO Dr. Albert Bourla speaks after U.S. Health and Human Services ...

Some, like Pfizer Inc. Chief Executive Officer Albert Bourla, were in Washington for the inauguration weekend. And within the corporate ranks, there was optimism that the new administration would ...

While the exact date of the meeting was not disclosed, Bourla said he and the health secretary nominee chatted civilly, conversing on topics they agreed on rather than straying to more divisive ...

Pour le président français, comme pour le prince souverain Albert II, Didier Guillaume était plus qu’un haut fonctionnaire, un grand commis d’État, il était un ami cher, trop tôt disparu.

Janet Glockler-Hooke told 880 CHED she was headed to a mall in St. Albert, Alta., on Saturday and when she turned into the parking lot, she noticed three men holding signs and flags that concerned ...

But in 2025, Moderna aims to reduce cash cost expenses by $1 billion, CEO Stéphane Bancel said at the J.P. Morgan Healthcare Conference in January. The company will report its 2024 full-year ...

Pfizer's CEO, Albert Bourla, Ph.D., has attempted to downplay the investor threat. At the J.P. Morgan Healthcare Conference earlier this month, he said that Starboard had only pushed for changes ...

In a statement Friday, CEO Stéphane Bancel noted that the company worked to reduce costs by 27% in 2024 compared to 2023. “In 2025, we remain focused on driving sales, delivering up to 10 ...

"In 2025, we remain focused on driving sales, delivering up to 10 product approvals through 2027, and expanding cost efficiencies across our business," CEO Stéphane Bancel said Friday. In ...